ARQULE (ARQL) Covered Calls

ARQULE covered calls ArQule, Inc. is a clinical-stage biotechnology company, which is engaged in the research and development of innovative cancer therapeutics directed toward molecular targets that play critical roles in the development of human cancers.

You can sell covered calls on ARQULE to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for ARQL (prices last updated Fri 4:16 PM ET):

ARQULE (ARQL) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
4.32 -0.38 4.05 4.90 1.1M - 0.5B
Covered Calls For ARQULE (ARQL)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Nov 16 5 0.25 4.65 5.4% 68.0%
Jan 18 5 1.35 3.55 38.0% 151%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

ArQule, Inc. is a clinical-stage biotechnology company that is engaged in the research and development of cancer therapeutics. Its products and research programs focuses on key biological processes that are central to human cancers. The company's programs also include research and development, drug discovery and advanced clinical testing. Its proprietary pipeline is directed towards molecular targets and biological processes with demonstrated roles in the development of human cancers. The company was founded in 1993 and is headquartered in Woburn, MA.